Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $11.59 billion. The enterprise value is $22.84 billion.
Market Cap | 11.59B |
Enterprise Value | 22.84B |
Important Dates
The next confirmed earnings date is Tuesday, April 29, 2025, before market open.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
THC has 95.12 million shares outstanding. The number of shares has decreased by -6.60% in one year.
Current Share Class | 95.12M |
Shares Outstanding | 95.12M |
Shares Change (YoY) | -6.60% |
Shares Change (QoQ) | -0.80% |
Owned by Insiders (%) | 1.20% |
Owned by Institutions (%) | 94.32% |
Float | 93.88M |
Valuation Ratios
The trailing PE ratio is 3.72 and the forward PE ratio is 9.98. THC's PEG ratio is 0.95.
PE Ratio | 3.72 |
Forward PE | 9.98 |
PS Ratio | 0.57 |
Forward PS | 0.55 |
PB Ratio | 2.78 |
P/TBV Ratio | n/a |
P/FCF Ratio | 10.38 |
P/OCF Ratio | 5.66 |
PEG Ratio | 0.95 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.66, with an EV/FCF ratio of 20.47.
EV / Earnings | 7.14 |
EV / Sales | 1.11 |
EV / EBITDA | 5.66 |
EV / EBIT | 7.10 |
EV / FCF | 20.47 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 1.68.
Current Ratio | 1.78 |
Quick Ratio | 1.54 |
Debt / Equity | 1.68 |
Debt / EBITDA | 3.22 |
Debt / FCF | 12.84 |
Interest Coverage | 3.90 |
Financial Efficiency
Return on equity (ROE) is 57.83% and return on invested capital (ROIC) is 9.02%.
Return on Equity (ROE) | 57.83% |
Return on Assets (ROA) | 7.03% |
Return on Invested Capital (ROIC) | 9.02% |
Return on Capital Employed (ROCE) | 13.07% |
Revenue Per Employee | $210,867 |
Profits Per Employee | $32,653 |
Employee Count | 98,000 |
Asset Turnover | 0.72 |
Inventory Turnover | 32.91 |
Taxes
In the past 12 months, THC has paid $1.18 billion in taxes.
Income Tax | 1.18B |
Effective Tax Rate | 22.56% |
Stock Price Statistics
The stock price has increased by +23.65% in the last 52 weeks. The beta is 1.78, so THC's price volatility has been higher than the market average.
Beta (5Y) | 1.78 |
52-Week Price Change | +23.65% |
50-Day Moving Average | 128.91 |
200-Day Moving Average | 142.98 |
Relative Strength Index (RSI) | 43.97 |
Average Volume (20 Days) | 1,778,112 |
Short Selling Information
The latest short interest is 2.43 million, so 2.56% of the outstanding shares have been sold short.
Short Interest | 2.43M |
Short Previous Month | 3.44M |
Short % of Shares Out | 2.56% |
Short % of Float | 2.59% |
Short Ratio (days to cover) | 1.39 |
Income Statement
In the last 12 months, THC had revenue of $20.67 billion and earned $3.20 billion in profits. Earnings per share was $32.70.
Revenue | 20.67B |
Gross Profit | 8.21B |
Operating Income | 3.22B |
Pretax Income | 3.76B |
Net Income | 3.20B |
EBITDA | 4.04B |
EBIT | 3.22B |
Earnings Per Share (EPS) | $32.70 |
Balance Sheet
The company has $3.02 billion in cash and $14.33 billion in debt, giving a net cash position of -$11.26 billion or -$118.35 per share.
Cash & Cash Equivalents | 3.02B |
Total Debt | 14.33B |
Net Cash | -11.26B |
Net Cash Per Share | -$118.35 |
Equity (Book Value) | 8.55B |
Book Value Per Share | 43.85 |
Working Capital | 3.37B |
Cash Flow
In the last 12 months, operating cash flow was $2.05 billion and capital expenditures -$931.00 million, giving a free cash flow of $1.12 billion.
Operating Cash Flow | 2.05B |
Capital Expenditures | -931.00M |
Free Cash Flow | 1.12B |
FCF Per Share | $11.73 |
Margins
Gross margin is 39.72%, with operating and profit margins of 15.57% and 15.49%.
Gross Margin | 39.72% |
Operating Margin | 15.57% |
Pretax Margin | 25.40% |
Profit Margin | 15.49% |
EBITDA Margin | 19.53% |
EBIT Margin | 15.57% |
FCF Margin | 5.40% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 6.60% |
Shareholder Yield | n/a |
Earnings Yield | 27.62% |
FCF Yield | 9.63% |
Analyst Forecast
The average price target for THC is $165.11, which is 35.88% higher than the current price. The consensus rating is "Buy".
Price Target | $165.11 |
Price Target Difference | 35.88% |
Analyst Consensus | Buy |
Analyst Count | 18 |
Revenue Growth Forecast (5Y) | 3.45% |
EPS Growth Forecast (5Y) | -6.73% |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 0.25:1.
Last Split Date | Oct 11, 2012 |
Split Type | Reverse |
Split Ratio | 0.25:1 |
Scores
THC has an Altman Z-Score of 1.73 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.73 |
Piotroski F-Score | 6 |